๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Targeted therapies for solid tumors: is the dream becoming a reality?

โœ Scribed by Martine J. Piccart-Gebhart; Ahmad Awada


Book ID
107384255
Publisher
Springer-Verlag
Year
2006
Tongue
English
Weight
48 KB
Volume
1
Category
Article
ISSN
1776-2596

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


STAT3 is essential for the maintenance o
โœ Claire Villalva; Severine Martin-Lannerรฉe; Ulrich Cortes; Fatima Dkhissi; Michel ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 762 KB

## Abstract Glioblastoma (GBM), the highestโ€grade form of gliomas, is the most frequent and the most aggressive. Recently, a subpopulation of cells with stem cells characteristics, commonly named โ€œtumorโ€initiating stem cellsโ€ (TISCs) or โ€œcancer stem cellsโ€ (CSCs) were identified in GBM. These cells

The tumor proteasome as a novel target f
โœ Vesna Milacic; Q. Ping Dou ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 599 KB

Although cisplatin plays a vital role in the treatment of several types of human cancer, its wide use is limited by the development of drug resistance and associated toxic side effects. Gold and gold complexes have been used to treat a wide range of ailments for many centuries. In recent years, the

The differentiation antigen NY-BR-1 is a
โœ Inka Seil; Claudia Frei; Holger Sรผltmann; Shirley K. Knauer; Knut Engels; Elke J ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 976 KB

## Abstract Antibodyโ€based cancer immunotherapy relies on the identification and characterization of target antigens and the development of potent antibodies recognizing the target. Here we report the expression analysis and molecular characterization of the differentiation antigen NYโ€BRโ€1, which w